The University of Chicago Header Logo

Connection

Bernhard Ortel to Matrix Metalloproteinase Inhibitors

Back to Details
This is a "connection" page, showing publications Bernhard Ortel has written about Matrix Metalloproteinase Inhibitors.
Bernhard Ortel
Connection Strength
0.068
Matrix Metalloproteinase Inhibitors
  1. The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model. Oncogene. 2002 Mar 27; 21(13):2089-96.
    View in: PubMed
    Score: 0.054
  2. Plasma matrix metalloproteinase 9 as biomarker of prostate cancer progression in Dunning (Copenhagen) rats. Prostate. 2003 Feb 15; 54(3):206-11.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.